Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AHC0612 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- IL-1 beta Antibody Cocktail
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- This clone can also be referred to as clone number 508A 7G8 R1/508A 4A2 L2.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 508A4A2 and 508A7G8
- Vial size
- 500 µg
- Concentration
- 1 mg/mL
- Storage
- 4° C
Submitted references Caspase activity is required for stimulated B lymphocytes to enter the cell cycle.
Caspase activity is required for stimulated B lymphocytes to enter the cell cycle.
Biological characterization of lipopolysaccharide from Treponema pectinovorum.
Biological characterization of lipopolysaccharide from Treponema pectinovorum.
Igf-I inhibits spontaneous apoptosis in human granulocytes.
Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA
Journal of immunology (Baltimore, Md. : 1950) 2003 Jun 15;170(12):6065-72
Journal of immunology (Baltimore, Md. : 1950) 2003 Jun 15;170(12):6065-72
Caspase activity is required for stimulated B lymphocytes to enter the cell cycle.
Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA
Journal of immunology (Baltimore, Md. : 1950) 2003 Jun 15;170(12):6065-72
Journal of immunology (Baltimore, Md. : 1950) 2003 Jun 15;170(12):6065-72
Biological characterization of lipopolysaccharide from Treponema pectinovorum.
Kesavalu L, Falk CW, Davis KJ, Steffen MJ, Xu X, Holt SC, Ebersole JL
Infection and immunity 2002 Jan;70(1):211-7
Infection and immunity 2002 Jan;70(1):211-7
Biological characterization of lipopolysaccharide from Treponema pectinovorum.
Kesavalu L, Falk CW, Davis KJ, Steffen MJ, Xu X, Holt SC, Ebersole JL
Infection and immunity 2002 Jan;70(1):211-7
Infection and immunity 2002 Jan;70(1):211-7
Igf-I inhibits spontaneous apoptosis in human granulocytes.
Kooijman R, Coppens A, Hooghe-Peters E
Endocrinology 2002 Apr;143(4):1206-12
Endocrinology 2002 Apr;143(4):1206-12
No comments: Submit comment
No validations: Submit validation data